Evidence map›Paper›PMID 30544849›Full record

ReviewProteomes2018

From Synapse to Function: A Perspective on the Role of Neuroproteomics in Elucidating Mechanisms of Drug Addiction.

Luis A Natividad, Matthew W Buczynski, Daniel B McClatchy, John R Yates

Open access · goldAbstract readReview
In one paragraph

Review in Proteomes, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.4field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. "Unraveling the role ofReceptors (Basel, Switzerland) · 2025
    Article
  3. Article
  4. Learning to become addicted, one synapse at a time.Neural regeneration research · 2024
    Article
  5. Review
  6. Circular RNA regulation and function in drug seeking phenotypes.Molecular and cellular neurosciences · 2023
    Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Luis A NatividadDepartment of Neuroscience, The Scripps Research Institute, La Jolla, CA 92037, USA. lnativi@scripps.edu.
Matthew W BuczynskiSchool of Neuroscience, Virginia Polytechnic Institute and State University, Blacksburg, VA 24061, USA. mwb@vt.edu.
Daniel B McClatchyDepartment of Molecular Medicine, The Scripps Research Institute, La Jolla, CA 92037, USA. dmcclat@scripps.edu.
John R YatesDepartment of Neuroscience, The Scripps Research Institute, La Jolla, CA 92037, USA. jyates@scripps.edu.
Scripps Research Institute · USVirginia Tech · US

Funding

TrainingP41GM103533 · NIGMS · UNIVERSITY OF WASHINGTON · PI FIELDS, STANLEY · 2012 to 2021
$20.7M
Quantitative Proteome Analysis of Brain DevelopmentR01MH067880 · NIMH · SCRIPPS RESEARCH INSTITUTE, THE · PI YATES III, JOHN R · 2003 to 2017
$7.1M
The role of the OEA synthase NAPE-PLD in nicotine signaling and rewardR00DA035865 · NIDA · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI BUCZYNSKI, MATTHEW WALLACE · 2017 to 2019
$747k
Identification of novel mechanisms in alcohol-induced cognitive dysfunctionK99AA025393 · NIAAA · SCRIPPS RESEARCH INSTITUTE, THE · PI NATIVIDAD, LUIS ALBERTO · 2017 to 2018
$284k
NIAAA NIH HHS K99 AA025393NIAAA NIH HHS K99-AA025393NIDA NIH HHS R00 DA035865NIDA NIH HHS R00-DA035865NIGMS NIH HHS P41 GM103533NIGMS NIH HHS P41-GM103533NIMH NIH HHS R01-MH067880
6 · The paper itself

Abstract

Drug addiction is a complex disorder driven by dysregulation in molecular signaling across several different brain regions. Limited therapeutic options currently exist for treating drug addiction and related psychiatric disorders in clinical populations, largely due to our incomplete understanding of the molecular pathways that influence addiction pathology. Recent work provides strong evidence that addiction-related behaviors emerge from the convergence of many subtle changes in molecular signaling networks that include neuropeptides (neuropeptidome), protein-protein interactions (interactome) and post-translational modifications such as protein phosphorylation (phosphoproteome). Advancements in mass spectrometry methodology are well positioned to identify these novel molecular underpinnings of addiction and further translate these findings into druggable targets for therapeutic development. In this review, we provide a general perspective of the utility of novel mass spectrometry-based approaches for addressing critical questions in addiction neuroscience, highlighting recent innovative studies that exemplify how functional assessments of the neuroproteome can provide insight into the mechanisms of drug addiction.

Indexed as

drug abuseinteractomeneuropeptidomicsneuroproteomephosphorylation

Identifiers

PMID30544849
PMCPMC6315754
OpenAlexW2904823818

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.